DAWN icon

Day One Biopharmaceuticals

149 hedge funds and large institutions have $1.2B invested in Day One Biopharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 49 increasing their positions, 44 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
149
Holders Change
+10
Holders Change %
+7.19%
% of All Funds
2.16%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
26
Increased
49
Reduced
44
Closed
16
Calls
$1.31M
Puts
$1.3M
Net Calls
+$13K
Net Calls Change
-$1.07M
Name Holding Trade Value Shares
Change
Shares
Change %
PC
151
Pier Capital
Connecticut
-$3.78M -258,685 Closed
Point72 Asset Management
152
Point72 Asset Management
Connecticut
-$1.28M -88,000 Closed
HF
153
HRT Financial
New York
-$1.08M -73,887 Closed
SG Americas Securities
154
SG Americas Securities
New York
-$945K -64,692 Closed
PCM
155
Prelude Capital Management
New York
-$621K -42,500 Closed
JAM
156
Jupiter Asset Management
United Kingdom
-$535K -36,671 Closed
GCP
157
GSA Capital Partners
United Kingdom
-$444K -30,378 Closed
Squarepoint
158
Squarepoint
New York
-$233K -15,927 Closed
Vontobel Holding
159
Vontobel Holding
Switzerland
-$226K -15,500 Closed
CSS
160
Cubist Systematic Strategies
Connecticut
-$210K -14,395 Closed
EFM
161
E Fund Management
China
-$184K -12,618 Closed
DTL
162
Dynamic Technology Lab
Singapore
-$156K -10,651 Closed
SIM
163
Sandia Investment Management
Massachusetts
-$87.3K -5,980 Closed
PNC Financial Services Group
164
PNC Financial Services Group
Pennsylvania
-$891 -61 Closed